Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Case report: painful peripheral neuropathy following treatment with docetaxel for breast cancer.

Wampler MA, Hamolsky D, Hamel K, Melisko M, Topp KS.

Clin J Oncol Nurs. 2005 Apr;9(2):189-93. Review.

PMID:
15853162
2.

A prospective surveillance model for physical rehabilitation of women with breast cancer: chemotherapy-induced peripheral neuropathy.

Stubblefield MD, McNeely ML, Alfano CM, Mayer DK.

Cancer. 2012 Apr 15;118(8 Suppl):2250-60. doi: 10.1002/cncr.27463. Review.

3.
4.

Techniques for the neurological examination of taxane-induced neuropathy.

Ohsumi S, Sunada Y.

Breast Cancer. 2004;11(1):86-91. Review.

PMID:
14718799
5.

Neurotoxicity of taxanes: symptoms and quality of life assessment.

Kuroi K, Shimozuma K.

Breast Cancer. 2004;11(1):92-9. Review.

PMID:
14718800
6.

Clinical challenges: chemotherapy-induced peripheral neuropathy.

Paice JA.

Semin Oncol Nurs. 2009 May;25(2 Suppl 1):S8-19. doi: 10.1016/j.soncn.2009.03.013. Review.

PMID:
19447319
7.

Docetaxel-related side effects and their management.

Baker J, Ajani J, Scotté F, Winther D, Martin M, Aapro MS, von Minckwitz G.

Eur J Oncol Nurs. 2008 Jul;12(3):253-68. doi: 10.1016/j.ejon.2008.03.006. Epub 2008 May 22. Review. Erratum in: Eur J Oncol Nurs. 2008 Dec;12(5):479. Dosage error in article text.

PMID:
18501674
8.

Difficult cases in pain management: use of methadone in a multifactorial approach.

Griffie J, Coyne P, Coyle N.

Clin J Oncol Nurs. 2006 Feb;10(1):45-9. Review.

PMID:
16482727
9.

Treatment and care of neurotoxicity from taxane anticancer agents.

Makino H.

Breast Cancer. 2004;11(1):100-4. Review.

PMID:
14718801
10.

Docetaxel-associated epiphora.

Kintzel PE, Michaud LB, Lange MK.

Pharmacotherapy. 2006 Jun;26(6):853-67. Review.

PMID:
16716138
11.

Taxanes for the adjuvant treatment of early breast cancer: systematic review and economic evaluation.

Ward S, Simpson E, Davis S, Hind D, Rees A, Wilkinson A.

Health Technol Assess. 2007 Oct;11(40):1-144. Review.

12.

Putting evidence into practice: evidence-based interventions for chemotherapy-induced peripheral neuropathy.

Visovsky C, Collins M, Abbott L, Aschenbrenner J, Hart C.

Clin J Oncol Nurs. 2007 Dec;11(6):901-13. Review.

PMID:
18063548
13.

Evaluation and management of peripheral neuropathy in diabetic patients with cancer.

Visovsky C, Meyer RR, Roller J, Poppas M.

Clin J Oncol Nurs. 2008 Apr;12(2):243-7. doi: 10.1188/08.CJON.243-247. Review.

PMID:
18390460
14.

Taxane induced neuropathy in patients affected by breast cancer: Literature review.

De Iuliis F, Taglieri L, Salerno G, Lanza R, Scarpa S.

Crit Rev Oncol Hematol. 2015 Oct;96(1):34-45. doi: 10.1016/j.critrevonc.2015.04.011. Epub 2015 May 11. Review.

PMID:
26004917
15.

Management of hand-foot syndrome in patients treated with capecitabine (Xeloda).

Lassere Y, Hoff P.

Eur J Oncol Nurs. 2004;8 Suppl 1:S31-40. Review.

PMID:
15341880
16.

Multiple myeloma, painful neuropathy, acupuncture?

Zhou Y, Garcia MK, Chang DZ, Chiang J, Lu J, Yi Q, Romaguera J, Delasalle K, Guo Y, Forman A, Fang W, Wang M.

Am J Clin Oncol. 2009 Jun;32(3):319-25. doi: 10.1097/COC.0b013e318173a520. Review.

PMID:
19887992
17.

Chemotherapy-induced nail changes: an unsightly nuisance.

Marrs J, Newton S.

Clin J Oncol Nurs. 2004 Oct;8(5):527-8. Review. No abstract available.

PMID:
15515285
18.

Palmar-plantar erythrodysesthesia (PPE): a literature review with commentary on experience in a cancer centre.

Webster-Gandy JD, How C, Harrold K.

Eur J Oncol Nurs. 2007 Jul;11(3):238-46. Epub 2007 Mar 9. Review.

PMID:
17350337
19.
20.

Chemotherapy-induced neuropathy.

Windebank AJ, Grisold W.

J Peripher Nerv Syst. 2008 Mar;13(1):27-46. doi: 10.1111/j.1529-8027.2008.00156.x. Review.

PMID:
18346229

Supplemental Content

Support Center